Idera finds unique mechanism behind third-generation antisense oligonucleotides Sep. 9, 2016 No Comments
Horizon Discovery collaborates with Fulcrum Therapeutics on CRISPR-based target discovery Sep. 6, 2016 No Comments
PET-based platform to screen and evaluate potential nanoparticles for photothermal treatment Aug. 11, 2016 No Comments
RSS